STAT News
What it covers
Latest stories it covered
John H. Powers III appointed permanent director of NIAID
Dr. John H. Powers III is appointed permanent director of the National Institute of Allergy and Infectious Diseases (NIAID), after serving as acting director. The appointment place...
American Cancer Society updates PSA screening guidance for prostate cancer ages and risk groups
The American Cancer Society updates its prostate cancer screening guidance, recommending routine prostate-specific antigen (PSA) blood testing for many men rather than emphasizing...
Trump administration delays Medicaid work requirement enforcement for states until July 1
The Trump administration gives U.S. states additional time before enforcing Medicaid work requirements that can result in losing coverage. Several outlets report the federal govern...
US loses measles elimination status after widespread outbreaks, PAHO reports
The United States has lost its measles elimination status after a reported determination by the Pan American Health Organization (PAHO) that the country is no longer stopping conti...
Trump administration funds early research into ibogaine for PTSD, addiction
Federal officials in the Trump administration announce new funding to support research into ibogaine, a psychedelic drug, with a focus on potential treatment for post-traumatic str...
FDA requires warnings on GLP-1 drugs for rare NAION-related vision loss
The U.S. Food and Drug Administration (FDA) is requiring new warnings on GLP-1 receptor agonist medicines about a rare eye condition, non-arteritic anterior ischemic optic neuropat...
Blackstone to fund Pfizer’s monthly berobenatide Phase 3 obesity drug studies
Pfizer is securing as much as $1.5 billion from Blackstone to support development of its monthly obesity drug berobenatide, according to multiple outlets. The funding is tied to ad...
Oura to acquire Counsel Health for $625 million to expand AI-driven medical care
Oura has agreed to acquire Counsel Health, an AI and on-demand doctor service, in an all-cash deal valued at $625 million. Multiple outlets report the move as part of Oura’s push t...
Senate health committee schedules vote on Trump FDA nominee Heidi Overton
The Senate health committee sets a vote for next week on Dr. Heidi Overton’s nomination to become commissioner of the Food and Drug Administration (FDA), though her approval is not...
Democrats press for disclosures in Trump administration most-favored-nation drug pricing deals
Incoming Democratic chairs of key U.S. congressional committees take steps toward investigating the Trump administration’s most-favored-nation (MFN) drug pricing agreements with ph...
PepGen reports promising early trial results for muscular dystrophy drug
PepGen says early data from a small study of its muscular dystrophy treatment look promising. Across the limited trial findings, the company reports that its therapy is showing sig...
WuXi AppTec removed from Pentagon list of Chinese military-linked companies
WuXi AppTec shares rise after the Pentagon removes the company from a US list of “Chinese military companies.” Multiple outlets say the delisting lifts restrictions and reputationa...
Eli Lilly’s GLP-1 pill Foundayo improves obstructive sleep apnea in late-stage trials
Eli Lilly reports that its daily GLP-1 weight-loss pill, Foundayo, reduces obstructive sleep apnea in late-stage clinical studies, with trial data indicating improvements in the co...
Ancient Siberian tomb yields 2,800-year-old evidence of cannabis used for psychoactive effects
Archaeologists say a 2,800-year-old tomb in southern Siberia contains the oldest directly dated archaeological evidence that people used cannabis for its psychoactive effects. Mult...
FDA investigates possible tumor risk in children treated with Novartis’ Zolgensma gene therapy
The US Food and Drug Administration is investigating reports of tumors, including malignancies, in children who received Novartis’ one-time gene therapy Zolgensma for spinal muscul...
Voters pass mixed state ballot measures on abortion, LGBTQ rights, and election rules
Voters in multiple U.S. states decided a wide range of ballot measures during the Nov. 3, 2026 midterm elections, with results split across abortion, LGBTQ-related issues, and elec...
Wisconsin reports infant death linked to measles outbreak, first in decades
Wisconsin health officials report that an infant has died from measles, marking the state’s first measles-related death in more than 30 years (with some outlets citing 35–36 years)...
CVS Health plans to split into two publicly traded companies separating pharmacies from insurance
CVS Health announces plans to break up its business into two separate publicly traded companies, separating retail pharmacy operations from its insurance and prescription-benefit u...
Revolution Medicines’ Rasonque sees strong early sales as analysts reassess launch expectations
Revolution Medicines’ new pancreatic cancer drug, Rasonque, is getting a strong early commercial response, prompting Wall Street analysts to reassess projections. Across outlets, c...
Massachusetts voters reject ballot measure to end recreational marijuana sales
Massachusetts voters decisively reject a ballot initiative that would have dismantled the state’s recreational cannabis industry, according to multiple outlets. The measure’s failu...